VectivBio Holding AG Ordinary Shares(NASDAQ:VECT) 
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for rare conditions. It develops Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the tre...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-01-03
P
O 16.85
H 16.85
L 16.85
C 16.85
V 0
10EMA 16.85
20EMA 16.85
60EMA 16.85
120EMA 16.85
250EMA 16.85